Wu JY — Endo Lab

2026

Mechanisms limiting the long-term anabolic effects of teriparatide (PTH 1-34) on bone.

JBMR plus ·doi:10.1093/jbmrpl/ziag093

Teriparatide, (recombinant human PTH 1-34) is an Food and Drug Administration (FDA)-approved anabolic therapy for osteoporosis. In patients with severe bone loss, daily teriparatide injections increase osteoblastic activity and bone turnove…

2024

Decreased NSD2 impairs stromal cell proliferation in human endometrium via reprogramming H3K36me2.

Reproduction (Cambridge, England) ·doi:10.1530/rep-23-0254

In briefThe proliferation of the endometrium is regulated by histone methylation. This study shows that decreased NSD2 impairs proliferative-phase endometrial stromal cell proliferation in patients with recurrent implantation failure via ep…

letter 2001

Androgen receptor trinucleotide polymorphism in endometriosis

Fertility and sterility ·doi:10.1016/s0015-0282(01)01894-5

article 2001

Endometriosis: Polymorphisms for Interleukin-1β (IL-1β)-511 Promoter, IL-1β Exon 5, and IL-1 Receptor Antagonist: Nonassociation with Endometriosis

Journal of assisted reproduction and genetics ·doi:10.1023/a:1016653127262

PurposeWe aimed to investigate if interleukin-1 beta (IL-1 beta) and IL-1 receptor antagonist (IL-1Ra) gene polymorphism could be used as markers of susceptibility in endometriosis.Materials and methodsWomen were divided into two groups: 1)…

case-report 1988

Catamenial hemoptysis--report of a case

Zhonghua yi xue za zhi = Chinese medical journal; Free China ed